Brainstorm Cell Therapeutics Inc. (NASDAQ:BCLI) is set to announce third quarter earning results on Thursday 15th October 2020, before market open.
Analysts surveyed by Thomson Reuters are predicting, BCLI to report 3Q20 loss of $ 0.26 per share.
For the full year, analysts anticipate loss of $ 1.15 per share bottom line.
Stock Performance
Shares of Brainstorm Cell Therapeutics Inc. traded low $ -0.26 or -1.53 percent on Wednesday, reaching $ 16.69 with volume of 270.40 thousand shares. Brainstorm Cell Therapeutics Inc. has traded high as $ 17.30 and has cracked $ 16.64 on the downward trend
According to the previous trading day, closing price of $ 16.69, representing a 373.46 % increase from the 52 week low of $ 3.58 and a 5.57 % decrease over the 52 week high of $ 17.95.
The company has a market capital of $ 526.24 million and is part of the Healthcare sector and Biotechnology industry.
Conference Call
Brainstorm Cell Therapeutics Inc. will be hosting a conference call at 8:00 AM eastern time on 15th October 2020, to discuss its 3Q20 financial results with the investment community. A live webcast with presentations will be available on the Internet by visiting the Company website www.brainstorm-cell.com
Brainstorm Cell Therapeutics Inc., a biotechnology company, engages in the development and commercialization of central nervous system (CNS) adult stem cell therapies designed to address the unmet medical needs of patients with debilitating neurodegenerative diseases. The company holds rights to develop and commercialize its NurOwn technology that utilizes a patients own cells, which are engineered outside the body, to produce and secrete factors known to promote neuronal survival. It is developing NurOwn for various neurodegenerative diseases, including its lead indication, which is in Phase III clinical trial for the treatment of amyotrophic lateral sclerosis, as well as in Phase II for the treatment of multiple sclerosis, and preclinical trial for Parkinsons disease, Huntingtons disease, and autism spectrum disorder.
